Latest Breaking News On - Dolon - Page 4 : comparemela.com

EU proposal may accelerate pharma innovation decline, industry group says

A major pharmaceutical rules overhaul, proposed by the European Commission in April, could see Europe's share in global research and development contract by a third to 21% by 2040 translating to 2 billion euros ($2.15 billion) per year in lost investment, industry group EFPIA said on Monday. The European Federation of Pharmaceutical Industries and Associations (EFPIA) says the Commission has not conducted a competitiveness impact assessment and if the new rules become law, they would accelerate the negative innovation trend in the EU and hit small and medium-sized enterprises the hardest. "Any changes to our incentives system would equally affect EU-based and foreign-based companies which bring medicines to the EU and, therefore, it would not put EU firms at a disadvantage," an EU Commission spokesperson said.

Pharma industry says rules fix to hit innovation, European Commission doesn't agree

Claims small biotech companies have already moved to the United States and China

Pharma industry says rules fix to hit innovation, European Commission doesn't agree – The Frontier Post

Global Media Representatives Gather in Chengdu for Collaborative Symposium

High-ranking members and directors of the World Association of Chinese Mass Media (WACMM) embarked on a mission of international collaboration as they visited Chengdu, Sichuan, China.

Global Media Leaders Converge in Sichuan for Collaborative Symposium